相似文献
1
Enough is Enough: Continuous Beta-Lactam Infusions for Treating Serious Infections.
J Assoc Med Microbiol Infect Dis Can. 2024 Dec 19;9(4):200-203. doi: 10.3138/jammi-2024-1104. eCollection 2024 Dec.
2
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.
3
Systemic antibiotics for treating diabetic foot infections.
Cochrane Database Syst Rev. 2015 Sep 4;2015(9):CD009061. doi: 10.1002/14651858.CD009061.pub2.
4
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779.
5
Prophylactic antibiotics for inhibiting preterm labour with intact membranes.
Cochrane Database Syst Rev. 2013 Dec 5;2013(12):CD000246. doi: 10.1002/14651858.CD000246.pub2.
6
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
Ann Pharmacother. 2009 Jul;43(7):1324-37. doi: 10.1345/aph.1L638. Epub 2009 Jul 7.
7
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
Am J Respir Crit Care Med. 2016 Sep 15;194(6):681-91. doi: 10.1164/rccm.201601-0024OC.
8
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections.
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008481. doi: 10.1002/14651858.CD008481.pub2.
9
Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
Crit Care. 2018 Sep 24;22(1):233. doi: 10.1186/s13054-018-2155-1.
本文引用的文献
1
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: implementation considerations.
Intensive Care Med. 2024 Dec;50(12):2150-2153. doi: 10.1007/s00134-024-07650-x. Epub 2024 Sep 23.
2
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
JAMA. 2024 Aug 27;332(8):638-648. doi: 10.1001/jama.2024.9803.
3
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
JAMA. 2024 Aug 27;332(8):629-637. doi: 10.1001/jama.2024.9779.
4
Infusion Therapy Standards of Practice, 9th Edition.
J Infus Nurs. 2024;47(1S Suppl 1):S1-S285. doi: 10.1097/NAN.0000000000000532.
5
Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.
N Engl J Med. 2023 Sep 28;389(13):1180-1190. doi: 10.1056/NEJMoa2304855.
6
Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review.
Drugs. 2023 Jul;83(11):967-983. doi: 10.1007/s40265-023-01893-6. Epub 2023 Jun 14.
7
Risk factors associated with catheter-related venous thrombosis: a meta-analysis.
Public Health. 2022 Apr;205:45-54. doi: 10.1016/j.puhe.2022.01.018. Epub 2022 Feb 26.
8
Optimizing Antimicrobial Drug Dosing in Critically Ill Patients.
Microorganisms. 2021 Jun 28;9(7):1401. doi: 10.3390/microorganisms9071401.
9
Optimizing antimicrobial use: challenges, advances and opportunities.
Nat Rev Microbiol. 2021 Dec;19(12):747-758. doi: 10.1038/s41579-021-00578-9. Epub 2021 Jun 22.
10
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741.
Zotero 插件